Molecular Dynamics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Molecular Dynamics

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jbershad who wrote (1)	2/17/1997 12:59:00 AM
From: Philip H. Lee	of 153

Analyst Recommendations on MDYN. MDYN reported 0.13 for 96Q4. See biz.yahoo.com 1-24-97: Robert W. Baird analysts Larry H. Neibor and Suey S. Wong have a rating of "2-Buy." Headline of research report: "Reports strong fourth quarter" FY97 est is 0.40, FY98 est is 0.50. 1-24-97: Hambrecht & Quist analysts Robert J. Olan and Rachel Leheny have a rating of "Buy." Headline: "The company soundly beats our EPS estimate." 96Q4 est was 0.10, FY97 est is 0.45. 1-1-97: Cowen & Co. analysts Michael G. Mullen and Daniel T. Lemaitre have a rating of "Buy." Headline: "Hospital Supply & Medical Tech: Growth outlook improves." 96Q4 est was 0.09. FY97 est is 0.45. Top 4 market makers for MDYN in Jan 1997: Robert W. Baird, 19.70% Hambrecht & Quist, 15.32%. Cowen & Co., 15.31%. Herzog, Heine, Geduld, 11.67%. Philip Disclaimer: Information obtained from sources believed to be reliable. However, information is NOT guaranteed to be accurate. Do your own research.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next